Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis

• Published in: Chinese medical journal Vol. 133; no. 12; pp. 1390 - 1396
• Main Authors: Chen, Jing-Yu, Qiao, Kun, Liu, Feng, Wu, Bo, Xu, Xin, Jiao, Guo-Qing, Lu, Rong-Guo, Li, Hui-Xing, Zhao, Jin, Huang, Jian, Yang, Yi, Lu, Xiao-Jie, Li, Jia-Shu, Jiang, Shu-Yun, Wang, Da-Peng, Hu, Chun-Xiao, Wang, Gui-Long, Huang, Dong-Xiao, Jiao, Guo-Hui, Wei, Dong, Ye, Shu-Gao, Huang, Jian-An, Zhou, Li, Zhang, Xiao-Qin, He, Jian-Xing
• Format: Journal Article
• Language: English
• Published: China The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license 20.06.2020; Lippincott Williams & Wilkins Ovid Technologies; Wuxi Lung Transplant Center, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Thoracic Surgery, Shenzhen Third People’s Hospital, Shenzhen, Guangdong 518100, China%Department of Thoracic Surgery/Oncology, State Key Laboratory and National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China%Department of Cardiothoracic Surgery, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China%Wuxi Fifth Hospital, Wuxi, Jiangsu 214000, China%Department of Respiratory Medicine and Critical Care Medicine, The First People’s Hospital of Lianyungang City, Lianyungang, Jiangsu 222061, China%Department of Critical Care Medicine, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Anesthesiology, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China%Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China; Wolters Kluwer Health; Wolters Kluwer
• Subjects: Aged; Betacoronavirus; Blood & organ donations; Coronary vessels; Coronavirus Infections - complications; Coronavirus Infections - mortality; Coronaviruses; COVID-19; Disease transmission; Extracorporeal Membrane Oxygenation; Heart; Hospitals; Humans; Lung Transplantation - methods; Lung transplants; Male; Medical personnel; Middle Aged; Original; Pandemics; Patients; Pneumonia, Viral - complications; Pneumonia, Viral - mortality; Pulmonary fibrosis; Pulmonary Fibrosis - mortality; Pulmonary Fibrosis - surgery; Rehabilitation; Respiratory distress syndrome; Respiratory Distress Syndrome - mortality; Respiratory Distress Syndrome - surgery; Respiratory failure; SARS-CoV-2; China; Acute respiratory distress syndrome; Pulmonary fibrosis; Coronavirus disease 2019; Sequential Organ Failure Assessment score; Lung transplantation

Critical patients with the coronavirus disease 2019 (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-sta...